SUPN

Supernus Pharmaceuticals Inc.

Price

$29.08

return (12m)

-20.40% Logo

p/e

7.61

p/bv

-57.19

DIVIDEND YIELD

27.96%
Price

SUPN price

Select period
Select period
Supernus Pharmaceuticals
If you had invested
If you had invested
exposure
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
15 years
ago, you would now have *
ago, today you would have:
*
*The amount considers the reinvestment of dividends.

Return on Investment SUPN

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
-10.81%
3 months
-21.20%
1 year
-20.40%
2 years
0.72%
5 years
-77.80%
10 years
0.00%
Fundamental indicators

Fundamentals SUPN

Check the fundamentals of Supernus Pharmaceuticals shares.

Valuation

P/E
7.61
Sector 0.86
Industry -1.70
P/BV
-57.19
Sector 1.75
Industry 1.22
P/Revenue (PSR)
2.50
Sector 1.42
Industry 2.25
EV/EBITDA
5.49
Sector -86.36
Industry -54.02
EV/EBIT
5.63
Sector -44.72
Industry -57.08
P/EBITDA
6.03
Sector -37.90
Industry -22.93
P/EBIT
6.18
Sector -57.08
Industry -29.03
P/Total Assets
2.58
Sector 0.80
Industry 0.76
P/Net Current Assets
-5.80
Sector -5.36
Industry -3.64
P/Working Capital
-6.85
Sector -0.42
Industry -2.88
EPS
3.82
Sector -0.68
Industry -1.30
BVPS
-0.51
Sector 4.14
Industry 2.38

Efficiency

Gross Margin
85.14%
Sector 48.43%
Industry 49.77%
EBITDA Margin
41.44%
Sector -253.37%
Industry -16,515,383.77%
EBIT Margin
40.64%
Sector -20.81%
Industry -29.34%
Net Profit Margins
32.85%
Sector -23.98%
Industry -31.08%
Asset Turnover
0.27
Sector 0.13
Industry 0.06

Profitability

ROE
-337.83%
Sector -28.78%
Industry -45.25%
ROA
32.82%
Sector -23.91%
Industry -46.82%
ROIC
66.75%
Sector -481.82%
Industry -746.00%

Dividends

Dividend yield
27.96%
Sector -
Industry -
Payout
212.78%
Sector -
Industry -

Debt

Current Ratio
0.61
Sector 1.86
Industry 2.64
Net Debt / EBITDA
-0.54
Sector -25.85
Industry -8.84
Net Debt / EBIT
-0.55
Sector -20.09
Industry -47.21
Net Debt / Equity
5.08
Sector -1.96
Industry -1.08
Gross Debt / Equity
0.00
Sector -1.92
Industry -0.21
Equity/Assets
-0.05
Sector 0.44
Industry 0.51
Liabilities/Assets
1.05
Sector 0.48
Industry 0.46

Growth

5Y Revenue CAGR
18.82%
Sector -
Industry -
5Y Earnings CAGR
53.21%
Sector -
Industry -
Fundamental indicators history

Fundamentals SUPN

Buy And Hold Investor Checklist

Supernus Pharmaceuticals Buy And Hold Investor Checklist

Price

COMPARING SUPN WITH OTHER STOCKS

Price

Stock vs Indice Comparison Tool

If you had invested
If you had invested
years ago
2 years
5 years
10 years
ago, you would now have *
ago, today you would have:
*
*This calculation reflects price variation only.

SUPN - Historical Dividends

Current Dividend Yield

27.96%

5-year average Dividend Yield

0.00%

Current Payout

212.78%

5-year average Payout

42.56%

DRAG THE FRAME TO SEE MORE DATA

type

Ex - Dividend Date

payment date

value

Dividends 11/02/2026 11/06/2026 8.13000000
Dividends 06/15/2016 07/29/2016 0.51350000
Dividends 09/16/2015 10/23/2015 0.16150000

ABOUT Supernus Pharmaceuticals

Logo Supernus Pharmaceuticals

Supernus Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

United States

21 years

Founded: 2005

2012

Time since IPO - 14 years

563

Employees

Market cap

$3.43 billion

$3.43 billion

Net worth

$-60.00 million

$-60,000,000.00

Assets

$1.33 billion

$1,332,000,000.00

Total Shares Outstanding

118.00 million

118,000,000

Average Daily Trading Volume

$3.04 million

$3,041,960.00

Shares

receitas e lucros

SUPN revenue and profits

Price

PROFIT X PRICE SUPN

Financials

Financial Results SUPN

DRAG THE FRAME TO SEE MORE DATA
Financials

SUPN cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

Asset, Revenue and Profit Growth - SUPN

Pontos Relevantes

SUPN balance sheet

DRAG THE FRAME TO SEE MORE DATA

Frequently Asked Questions

What is the price of Supernus Pharmaceuticals (SUPN) today?

The current price of Supernus Pharmaceuticals (SUPN) is $29.08. The stock began the year trading around $49.70 and is currently priced at $29.08. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Supernus Pharmaceuticals (SUPN) pay dividends?

In the last year, Supernus Pharmaceuticals (SUPN) distributed dividends in the month of November, totaling $8.13. The Dividend Yield for the last 12 months is 27.96%.

Is Supernus Pharmaceuticals (SUPN) a good investment?

Supernus Pharmaceuticals (SUPN) is currently trading at $29.08 with a P/E ratio of 7.61. This represents a 45,367% premium compared to its historical average P/E. Over the past year, the stock paid $8.13 in dividends, resulting in a dividend yield of 27.96%. The total shareholder return over the same period was -20.40%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Supernus Pharmaceuticals (SUPN) stock?

You can buy Supernus Pharmaceuticals (SUPN) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol SUPN and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Supernus Pharmaceuticals (SUPN) yield today?

Over the past month, Supernus Pharmaceuticals (SUPN) has returned -10.81% — -20.40% over the past year, and -77.80% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 8.13 per share in dividends, resulting in a dividend yield of 27.96%.

If you were to purchase 100 shares of Supernus Pharmaceuticals (SUPN) today at the current price of $29.08 your total investment would be $2,908.00.

Based on historical performance, the investment would have grown to approximately:

  • $2,314.77 after 1 year
  • $645.58 after 5 years
  • $2,908.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.